Clinical Trials

Tonix is committed to improving the lives of patients by identifying, researching and developing promising therapies which have the potential to address unmet needs.

TNX-102 SL

Phase III – Fibromyalgia

A double-blind, randomized, multicenter, placebo-controlled study to evaluate the efficacy and safety of TNX-102 SL taken daily at bedtime in patients with Fibromyalgia in 30 locations in the US.

For more information, visit https://clinicaltrials.gov/ (NCT05273749) and https://resilientstudy.com/.

To see if you pre-qualify, please visit https://resilientstudy.com/ and click “See if You Qualify” to find a participating site near you. If no sites are found near you, please try again in a month as some sites may be available later.

Patient Resources

The below are a few patient advocacy organizations that provide resources and support to those affected by Fibromyalgia: